We are live on ! Find out more
BG

Bollard Group Portfolio holdings

AUM $3.39B
1-Year Est. Return 1.06%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
-1.06%
3 Year Est. Return
+72.63%
5 Year Est. Return
+112.03%
10 Year Est. Return
+415.67%
AUM
$4.37B
AUM Growth
+$566M
Cap. Flow
+$197M
Cap. Flow %
4.52%
Top 10 Hldgs %
75.62%
Holding
311
New
26
Increased
196
Reduced
22
Closed
17

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$25.9M
2
MSGS icon
Madison Square Garden
MSGS
+$23.3M
3
MSFT icon
Microsoft
MSFT
+$14.8M
4
AMZN icon
Amazon
AMZN
+$12.7M
5
NVDA icon
NVIDIA
NVDA
+$12.5M

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$41.6M
2
DINO icon
HF Sinclair
DINO
+$6.4M
3
UNH icon
UnitedHealth
UNH
+$3.72M
4
TPYP icon
Tortoise North American Pipeline ETF
TPYP
+$2.48M
5
FANG icon
Diamondback Energy
FANG
+$2.11M

Sector Composition

Rank Sector Weight
1 Healthcare 56.07%
2 Technology 8.45%
3 Energy 6.73%
4 Consumer Discretionary 4.64%
5 Utilities 4.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MLPX icon
76
Global X MLP & Energy Infrastructure ETF
MLPX
$3.68B
$2.85M 0.07%
45,475
+532
+1% +$32.3K
VZ icon
77
Verizon
VZ
$194B
$2.85M 0.07%
65,782
+3,675
+6% +$159K
MAS icon
78
Masco
MAS
$16B
$2.82M 0.06%
43,794
+211
+0.5% +$13.3K
PG icon
79
Procter & Gamble
PG
$343B
$2.79M 0.06%
17,503
+1,491
+9% +$243K
BNTX icon
80
BioNTech
BNTX
$22.6B
$2.75M 0.06%
+25,780
New +$2.6M
MO icon
81
Altria Group
MO
$122B
$2.72M 0.06%
46,440
+2,438
+6% +$143K
DKNG icon
82
DraftKings
DKNG
$11.4B
$2.55M 0.06%
59,417
– –
PAYX icon
83
Paychex
PAYX
$40.4B
$2.38M 0.05%
16,396
+1,447
+10% +$218K
AMLP icon
84
Alerian MLP ETF
AMLP
$13B
$2.33M 0.05%
47,669
+627
+1% +$30.4K
ED icon
85
Consolidated Edison
ED
$41.6B
$2.28M 0.05%
22,685
+1,229
+6% +$130K
MDLZ icon
86
Mondelez International
MDLZ
$77.7B
$2.11M 0.05%
31,238
+406
+1% +$27.1K
JCI icon
87
Johnson Controls International
JCI
$87.5B
$2.07M 0.05%
19,570
+1,587
+9% +$146K
HD icon
88
Home Depot
HD
$332B
$2.04M 0.05%
5,556
+227
+4% +$82.1K
ACRS icon
89
Aclaris Therapeutics
ACRS
$730M
$1.92M 0.04%
1,352,276
-71,900
-5% -$97.3K
LMT icon
90
Lockheed Martin
LMT
$134B
$1.91M 0.04%
4,121
+200
+5% +$93.6K
ENTG icon
91
Entegris
ENTG
$19.7B
$1.85M 0.04%
+22,947
New +$1.74M
CLX icon
92
Clorox
CLX
$11.6B
$1.83M 0.04%
15,234
+2,091
+16% +$279K
RVTY icon
93
Revvity
RVTY
$12.3B
$1.78M 0.04%
+18,439
New +$1.74M
SLDB icon
94
Solid Biosciences
SLDB
$771M
$1.76M 0.04%
+361,660
New +$1.28M
INSM icon
95
Insmed
INSM
$23.2B
$1.73M 0.04%
+17,191
New +$1.31M
SHEL icon
96
Shell
SHEL
$245B
$1.71M 0.04%
24,319
+1,310
+6% +$87.8K
MTCH icon
97
Match Group
MTCH
$8.84B
$1.69M 0.04%
54,558
+356
+0.7% +$10.6K
NGG icon
98
National Grid
NGG
$82.7B
$1.64M 0.04%
22,374
-45
-0.2% -$3.09K
IRON icon
99
Disc Medicine
IRON
$2.83B
$1.62M 0.04%
+30,635
New +$1.44M
NEE icon
100
NextEra Energy
NEE
$187B
$1.56M 0.04%
22,441
+792
+4% +$55K
2 3
4
5 6

Similar funds

BCM
Becker Capital Management Portland, Oregon $3.4B AUM 24.68% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
MCM
Marsico Capital Management Denver, Colorado $3.4B AUM 51.58% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
EFM
E Fund Management Guangzhou, China $3.37B AUM
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return

Bollard Group's Q2 2025 Portfolio in Review

As of Q2 2025, Bollard Group held 311 positions worth $4.37B, up 15% from $3.81B the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Bollard Group deployed $197M of net new capital in Q2 2025, opening 26 new positions and adding to 196 existing holdings. Its largest new stake was Madison Square Garden: 121,000 shares worth $25.3M.

By sector, the portfolio is most concentrated in Healthcare at 56% of assets, down from 61% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Boston Scientific, an estimated $41.6M trimmed.

  • Bollard Group's largest Q2 2025 buy was Madison Square Garden: 121,000 shares worth $25.3M.
  • Bollard Group added most to Thermo Fisher Scientific in Q2 2025, an estimated $25.9M increase.
  • Bollard Group's biggest Q2 2025 reduction was Boston Scientific, cutting an estimated $41.6M.
  • Bollard Group fully exited HF Sinclair in Q2 2025, selling an estimated $6.4M.
  • Bollard Group's ten largest holdings make up 76% of its $4.37B portfolio in Q2 2025.
  • Bollard Group opened 26 new positions and closed 17 in Q2 2025.
  • Bollard Group's portfolio value rose 15% quarter-over-quarter to $4.37B.

Based on Bollard Group's 13F filing for Q2 2025, filed 13 Aug 2025.